I agree that this site is using cookies. You can find further informations here.
X
Lemoli, Roberto M.
~ 200  results:
Search for persons X
?
1

Literature review and expert opinion on the treatment of hi..:

Palmieri, Raffaele ; Billio, Atto ; Ferrara, Felicetto...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine ..:

Pratz, Keith W. ; Jonas, Brian A. ; Pullarkat, Vinod...
American Journal of Hematology.  99 (2024)  4 - p. 615-624 , 2024
Link: https://doi.org/10.1002/..
 
?
3

P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE M..:

Efficace, Fabio ; Cannella, Laura ; Thomas, Xavier...
HemaSphere.  7 (2023)  S3 - p. e90211c0 , 2023
Link: https://doi.org/10.1097/..
 
?
4

Real-world experience with CPX-351 in high-risk acute myelo..:

Lemoli, Roberto M. ; Montesinos, Pau ; Jain, Akriti
Critical Reviews in Oncology/Hematology.  185 (2023)  - p. 103984 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Triple Combination Therapy With 2 Antivirals and Monoclonal..:

Mikulska, Malgorzata ; Sepulcri, Chiara ; Dentone, Chiara...
Clinical Infectious Diseases.  77 (2023)  2 - p. 280-286 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Daratumumab in the treatment of C3 glomerulopathy with mono..:

Esposito, Pasquale ; Picciotto, Daniela ; Costigliolo, Francesca...
Frontiers in Medicine.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma ..:

Becherini, Pamela ; Soncini, Debora ; Ravera, Silvia...
Antioxidants.  12 (2023)  2 - p. 494 , 2023
Link: https://doi.org/10.3390/..
 
?
8

A Prognostic Model to Predict Ruxolitinib Discontinuation a..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Bonifacio, Massimiliano...
Cancers.  15 (2023)  20 - p. 5027 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Donor selection for adoptive immunotherapy with NK cells in..:

Meazza, Raffaella ; Ruggeri, Loredana ; Guolo, Fabio...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

Targeting the deacetylase SIRT6 unveils spliceosome deregul..:

Gelli, Elisa ; Soncini, Debora ; Becherini, Pamela...
Blood Advances.  7 (2023)  14 - p. 3472-3478 , 2023
Link: https://doi.org/10.1182/..
 
?
11

Impact of Venetoclax and Azacitidine in Treatment-Naïve Pat..:

Pollyea, Daniel A. ; DiNardo, Courtney D. ; Arellano, Martha L....
Clinical Cancer Research.  28 (2022)  13 - p. 2753-2761 , 2022
Link: https://doi.org/10.1158/..
 
?
12

Measurable Residual Disease in High-Risk Acute Myeloid Leuk..:

Cluzeau, Thomas ; Lemoli, Roberto M. ; McCloskey, James.
Cancers.  14 (2022)  5 - p. 1278 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Peripheral blasts are associated with responses to ruxoliti..:

Palandri, Francesca ; Bartoletti, Daniela ; Iurlo, Alessandra...
Cancer.  128 (2022)  13 - p. 2449-2454 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Process development and validation of expanded regulatory T..:

Lavazza, Cristiana ; Budelli, Silvia ; Montelatici, Elisa...
Journal of Translational Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
15

INCB84344-201: Ponatinib and steroids in frontline therapy ..:

Martinelli, Giovanni ; Papayannidis, Cristina ; Piciocchi, Alfonso...
Blood Advances.  6 (2022)  6 - p. 1742-1753 , 2022
Link: https://doi.org/10.1182/..
 
1-15